$PPL
PPL Corp

2020 Q1 Form 10-Q Financial Statement

#000092222420000024 Filed on May 08, 2020

View on sec.gov

Income Statement

Concept 2020 Q1 2019 Q1
Revenue $1.440B $2.079B
YoY Change -30.74% -2.21%
Cost Of Revenue $201.0M $250.0M
YoY Change -19.6% 3.73%
Gross Profit $1.239B $1.829B
YoY Change -32.26% -2.97%
Gross Profit Margin 86.04% 87.97%
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $250.0M $284.0M
YoY Change -11.97% 5.58%
% of Gross Profit 20.18% 15.53%
Operating Expenses $815.0M $1.048B
YoY Change -22.23% 1.35%
Operating Profit $424.0M $781.0M
YoY Change -45.71% -8.23%
Interest Expense $154.0M $241.0M
YoY Change -36.1% 0.84%
% of Operating Profit 36.32% 30.86%
Other Income/Expense, Net -$5.000M $52.00M
YoY Change -109.62% -220.93%
Pretax Income $265.0M $592.0M
YoY Change -55.24% 4.04%
Income Tax $61.00M $126.0M
% Of Pretax Income 23.02% 21.28%
Net Earnings $554.0M $466.0M
YoY Change 18.88% 3.1%
Net Earnings / Revenue 38.47% 22.41%
Basic Earnings Per Share $0.72 $0.65
Diluted Earnings Per Share $0.72 $0.64
COMMON SHARES
Basic Shares Outstanding 767.9M shares 721.0M shares
Diluted Shares Outstanding 768.7M shares 730.0M shares

Balance Sheet

Concept 2020 Q1 2019 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $915.0M $518.0M
YoY Change 76.64% -17.65%
Cash & Equivalents $915.0M $518.0M
Short-Term Investments
Other Short-Term Assets $102.0M $62.00M
YoY Change 64.52% 26.53%
Inventory $320.0M $274.0M
Prepaid Expenses $155.0M $157.0M
Receivables $730.0M $749.0M
Other Receivables $107.0M $104.0M
Total Short-Term Assets $2.956B $2.429B
YoY Change 21.7% -2.45%
LONG-TERM ASSETS
Property, Plant & Equipment $36.84B $35.31B
YoY Change 4.33% 4.66%
Goodwill $3.178B $3.260B
YoY Change -2.52% -1.27%
Intangibles $748.0M $728.0M
YoY Change 2.75% 3.56%
Long-Term Investments
YoY Change
Other Assets $365.0M $290.0M
YoY Change 25.86% 107.14%
Total Long-Term Assets $6.537B $6.831B
YoY Change -4.3% 10.86%
TOTAL ASSETS
Total Short-Term Assets $2.956B $2.429B
Total Long-Term Assets $6.537B $6.831B
Total Assets $46.33B $44.57B
YoY Change 3.95% 5.14%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $833.0M $823.0M
YoY Change 1.22% -1.56%
Accrued Expenses $352.0M $353.0M
YoY Change -0.28% 9.29%
Deferred Revenue
YoY Change
Short-Term Debt $1.696B $1.428B
YoY Change 18.77% -1.99%
Long-Term Debt Due $1.170B $202.0M
YoY Change 479.21% -19.2%
Total Short-Term Liabilities $5.322B $4.061B
YoY Change 31.05% -4.18%
LONG-TERM LIABILITIES
Long-Term Debt $20.67B $21.11B
YoY Change -2.1% 4.45%
Other Long-Term Liabilities $481.0M $469.0M
YoY Change 2.56% 6.35%
Total Long-Term Liabilities $7.095B $7.220B
YoY Change -1.73% 6.8%
TOTAL LIABILITIES
Total Short-Term Liabilities $5.322B $4.061B
Total Long-Term Liabilities $7.095B $7.220B
Total Liabilities $12.42B $11.28B
YoY Change 10.07% 2.57%
SHAREHOLDERS EQUITY
Retained Earnings $5.360B $4.761B
YoY Change 12.58% 17.93%
Common Stock $12.25B $11.06B
YoY Change 10.75% 6.14%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $13.24B $12.17B
YoY Change
Total Liabilities & Shareholders Equity $46.33B $44.57B
YoY Change 3.95% 5.14%

Cashflow Statement

Concept 2020 Q1 2019 Q1
OPERATING ACTIVITIES
Net Income $554.0M $466.0M
YoY Change 18.88% 3.1%
Depreciation, Depletion And Amortization $250.0M $284.0M
YoY Change -11.97% 5.58%
Cash From Operating Activities $692.0M $474.0M
YoY Change 45.99% -16.25%
INVESTING ACTIVITIES
Capital Expenditures $616.0M $729.0M
YoY Change -15.5% -2.8%
Acquisitions
YoY Change
Other Investing Activities $3.000M -$5.000M
YoY Change -160.0% -266.67%
Cash From Investing Activities -$833.0M -$722.0M
YoY Change 15.37% -4.12%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $20.00M $22.00M
YoY Change -9.09% -78.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $240.0M $142.0M
YoY Change 69.01% -57.1%
NET CHANGE
Cash From Operating Activities $692.0M $474.0M
Cash From Investing Activities -$833.0M -$722.0M
Cash From Financing Activities $240.0M $142.0M
Net Change In Cash $77.00M -$103.0M
YoY Change -174.76% -172.54%
FREE CASH FLOW
Cash From Operating Activities $692.0M $474.0M
Capital Expenditures $616.0M $729.0M
Free Cash Flow $76.00M -$255.0M
YoY Change -129.8% 38.59%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q1 dei Amendment Flag
AmendmentFlag
false
CY2020Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2020Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2020Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
CY2020Q1 dei Entity Central Index Key
EntityCentralIndexKey
0000922224
CY2020Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2020Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2020Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2019Q1 ppl Net Income Available To Common Shareowners
NetIncomeAvailableToCommonShareowners
466000000 USD
CY2020Q1 ppl Net Income Available To Common Shareowners
NetIncomeAvailableToCommonShareowners
553000000 USD
CY2020Q1 ppl Tax Effect Of New Accounting Principle In Period Of Adoption
TaxEffectOfNewAccountingPrincipleInPeriodOfAdoption
0 USD
CY2019Q4 ppl Unbilled Contracts Receivable Allowancefor Credit Loss Current
UnbilledContractsReceivableAllowanceforCreditLossCurrent
0 USD
CY2020Q1 ppl Unbilled Contracts Receivable Allowancefor Credit Loss Current
UnbilledContractsReceivableAllowanceforCreditLossCurrent
3000000 USD
CY2019Q1 ppl Votes Per Share Of Common Stock
VotesPerShareOfCommonStock
1 vote
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
58000000 USD
CY2020Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
62000000 USD
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2019Q4 us-gaap Guarantee Obligations Current Carrying Value
GuaranteeObligationsCurrentCarryingValue
5000000 USD
CY2019Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax
-4000000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax
2000000 USD
CY2019Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax
-6000000 USD
CY2019Q1 us-gaap Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax
-1000000 USD
CY2020Q1 us-gaap Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax
0 USD
CY2019Q1 us-gaap Other Comprehensive Income Foreign Currency Translation Gain Loss Arising During Period Tax
OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax
0 USD
CY2020Q1 us-gaap Other Comprehensive Income Foreign Currency Translation Gain Loss Arising During Period Tax
OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax
0 USD
CY2020Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2019Q1 us-gaap Other Comprehensive Income Loss Amortization Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Prior Service Cost Credit Tax
OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax
0 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Amortization Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Prior Service Cost Credit Tax
OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax
0 USD
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1560000000 shares
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
767233000 shares
CY2020Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
768266000 shares
CY2019Q1 us-gaap Gain Loss On Discontinuation Of Interest Rate Cash Flow Hedge Due To Forecasted Transaction Probable Of Not Occurring Net
GainLossOnDiscontinuationOfInterestRateCashFlowHedgeDueToForecastedTransactionProbableOfNotOccurringNet
0 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax
0 USD
CY2019Q1 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Gain Loss Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax
-5000000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Gain Loss Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax
-12000000 USD
CY2020Q1 dei Document Type
DocumentType
10-Q
CY2020Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2020Q1 dei Document Period End Date
DocumentPeriodEndDate
2020-03-31
CY2020Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2020Q1 dei Entity File Number
EntityFileNumber
1-11459
CY2020Q1 dei Entity Registrant Name
EntityRegistrantName
PPL Corporation
CY2020Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
23-2758192
CY2020Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
Two North Ninth Street
CY2020Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Allentown,
CY2020Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
PA
CY2020Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
18101-1179
CY2020Q1 dei City Area Code
CityAreaCode
(610)
CY2020Q1 dei Local Phone Number
LocalPhoneNumber
774-5151
CY2020Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
PA
CY2020Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2020Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2020Q1 dei Entity Shell Company
EntityShellCompany
false
CY2020Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
768763491 shares
CY2020Q1 us-gaap Revenues
Revenues
2054000000 USD
CY2019Q1 us-gaap Revenues
Revenues
2079000000 USD
CY2020Q1 us-gaap Fuel Costs
FuelCosts
163000000 USD
CY2019Q1 us-gaap Fuel Costs
FuelCosts
194000000 USD
CY2020Q1 ppl Purchased Power And Gas
PurchasedPowerAndGas
201000000 USD
CY2019Q1 ppl Purchased Power And Gas
PurchasedPowerAndGas
250000000 USD
CY2020Q1 us-gaap Utilities Operating Expense Maintenance Operations And Other Costs And Expenses
UtilitiesOperatingExpenseMaintenanceOperationsAndOtherCostsAndExpenses
476000000 USD
CY2019Q1 us-gaap Utilities Operating Expense Maintenance Operations And Other Costs And Expenses
UtilitiesOperatingExpenseMaintenanceOperationsAndOtherCostsAndExpenses
490000000 USD
CY2020Q1 us-gaap Utilities Operating Expense Depreciation And Amortization
UtilitiesOperatingExpenseDepreciationAndAmortization
317000000 USD
CY2019Q1 us-gaap Utilities Operating Expense Depreciation And Amortization
UtilitiesOperatingExpenseDepreciationAndAmortization
284000000 USD
CY2020Q1 us-gaap Utilities Operating Expense Taxes
UtilitiesOperatingExpenseTaxes
80000000 USD
CY2019Q1 us-gaap Utilities Operating Expense Taxes
UtilitiesOperatingExpenseTaxes
80000000 USD
CY2020Q1 us-gaap Utilities Operating Expense
UtilitiesOperatingExpense
1237000000 USD
CY2019Q1 us-gaap Utilities Operating Expense
UtilitiesOperatingExpense
1298000000 USD
CY2020Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
817000000 USD
CY2019Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
781000000 USD
CY2020Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
125000000 USD
CY2019Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
52000000 USD
CY2020Q1 us-gaap Interest Expense
InterestExpense
248000000 USD
CY2019Q1 us-gaap Interest Expense
InterestExpense
241000000 USD
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
694000000 USD
CY2019Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
592000000 USD
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
140000000 USD
CY2019Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
126000000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
554000000 USD
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
466000000 USD
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.72
CY2019Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.65
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.72
CY2019Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.64
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
767948000 shares
CY2019Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
721023000 shares
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
768738000 shares
CY2019Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
729953000 shares
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
554000000 USD
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
466000000 USD
CY2020Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-61000000 USD
CY2019Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
294000000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
8000000 USD
CY2019Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
-19000000 USD
CY2020Q1 us-gaap Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
0 USD
CY2019Q1 us-gaap Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
-3000000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
3000000 USD
CY2019Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
-24000000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Amortization Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Prior Service Cost Credit Net Of Tax
OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax
1000000 USD
CY2019Q1 us-gaap Other Comprehensive Income Loss Amortization Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Prior Service Cost Credit Net Of Tax
OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax
0 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Gain Loss Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax
-47000000 USD
CY2019Q1 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Gain Loss Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax
-21000000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-8000000 USD
CY2019Q1 us-gaap Pension And Other Postretirement Benefits Expense Reversal Of Expense Noncash
PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash
-66000000 USD
CY2020Q1 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
106000000 USD
CY2020Q1 us-gaap Share Based Compensation
ShareBasedCompensation
6000000 USD
CY2019Q1 us-gaap Share Based Compensation
ShareBasedCompensation
14000000 USD
CY2019Q1 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
89000000 USD
CY2019Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
317000000 USD
CY2020Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
546000000 USD
CY2019Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
783000000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
554000000 USD
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
466000000 USD
CY2020Q1 us-gaap Depreciation
Depreciation
317000000 USD
CY2019Q1 us-gaap Depreciation
Depreciation
284000000 USD
CY2020Q1 us-gaap Adjustment For Amortization
AdjustmentForAmortization
12000000 USD
CY2019Q1 us-gaap Adjustment For Amortization
AdjustmentForAmortization
22000000 USD
CY2020Q1 us-gaap Pension And Other Postretirement Benefits Expense Reversal Of Expense Noncash
PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash
-52000000 USD
CY2020Q1 ppl Unrealizedgainsonderivativesandotherhedgingactivities
Unrealizedgainsonderivativesandotherhedgingactivities
57000000 USD
CY2019Q1 ppl Unrealizedgainsonderivativesandotherhedgingactivities
Unrealizedgainsonderivativesandotherhedgingactivities
-53000000 USD
CY2020Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-17000000 USD
CY2019Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
3000000 USD
CY2020Q1 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
35000000 USD
CY2019Q1 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
57000000 USD
CY2020Q1 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-63000000 USD
CY2019Q1 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-94000000 USD
CY2020Q1 ppl Net Change Unbilled Revenues
NetChangeUnbilledRevenues
-68000000 USD
CY2019Q1 ppl Net Change Unbilled Revenues
NetChangeUnbilledRevenues
-48000000 USD
CY2020Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-13000000 USD
CY2019Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-31000000 USD
CY2020Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
76000000 USD
CY2019Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
86000000 USD
CY2020Q1 us-gaap Increase Decrease In Regulatory Assets And Liabilities
IncreaseDecreaseInRegulatoryAssetsAndLiabilities
25000000 USD
CY2019Q1 us-gaap Increase Decrease In Regulatory Assets And Liabilities
IncreaseDecreaseInRegulatoryAssetsAndLiabilities
25000000 USD
CY2020Q1 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
59000000 USD
CY2019Q1 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
48000000 USD
CY2020Q1 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
-95000000 USD
CY2019Q1 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
-72000000 USD
CY2020Q1 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-24000000 USD
CY2019Q1 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
21000000 USD
CY2020Q1 us-gaap Pension Contributions
PensionContributions
125000000 USD
CY2019Q1 us-gaap Pension Contributions
PensionContributions
127000000 USD
CY2020Q1 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-42000000 USD
CY2019Q1 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
20000000 USD
CY2020Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
20000000 USD
CY2020Q1 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
2000000 USD
CY2019Q1 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-10000000 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
692000000 USD
CY2019Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
474000000 USD
CY2020Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
826000000 USD
CY2019Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
729000000 USD
CY2020Q1 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
0 USD
CY2019Q1 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
55000000 USD
CY2020Q1 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
0 USD
CY2019Q1 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
57000000 USD
CY2020Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
7000000 USD
CY2019Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-5000000 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-833000000 USD
CY2019Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-722000000 USD
CY2019Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
22000000 USD
CY2020Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
317000000 USD
CY2019Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
296000000 USD
CY2020Q1 us-gaap Proceeds From Short Term Debt Maturing In More Than Three Months
ProceedsFromShortTermDebtMaturingInMoreThanThreeMonths
200000000 USD
CY2019Q1 us-gaap Proceeds From Short Term Debt Maturing In More Than Three Months
ProceedsFromShortTermDebtMaturingInMoreThanThreeMonths
0 USD
CY2020Q1 us-gaap Proceeds From Repayments Of Short Term Debt Maturing In Three Months Or Less
ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess
345000000 USD
CY2019Q1 us-gaap Proceeds From Repayments Of Short Term Debt Maturing In Three Months Or Less
ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess
424000000 USD
CY2020Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-8000000 USD
CY2019Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-8000000 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
240000000 USD
CY2019Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
142000000 USD
CY2020Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1000000 USD
CY2019Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3000000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
100000000 USD
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-103000000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
836000000 USD
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
643000000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
936000000 USD
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
540000000 USD
CY2020Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
282000000 USD
CY2019Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
322000000 USD
CY2020Q1 ppl Intangible Asset Expenditures Incurred But Not Yet Paid
IntangibleAssetExpendituresIncurredButNotYetPaid
87000000 USD
CY2019Q1 ppl Intangible Asset Expenditures Incurred But Not Yet Paid
IntangibleAssetExpendituresIncurredButNotYetPaid
64000000 USD
CY2020Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
915000000 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
815000000 USD
CY2020Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
730000000 USD
CY2020Q1 us-gaap Assets Noncurrent
AssetsNoncurrent
6537000000 USD
CY2019Q4 us-gaap Derivative Instruments And Hedges
DerivativeInstrumentsAndHedges
147000000 USD
CY2020Q1 us-gaap Other Assets Current
OtherAssetsCurrent
102000000 USD
CY2019Q4 us-gaap Other Assets Current
OtherAssetsCurrent
98000000 USD
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
687000000 USD
CY2020Q1 us-gaap Nontrade Receivables Current
NontradeReceivablesCurrent
107000000 USD
CY2019Q4 us-gaap Nontrade Receivables Current
NontradeReceivablesCurrent
105000000 USD
CY2020Q1 us-gaap Unbilled Contracts Receivable
UnbilledContractsReceivable
434000000 USD
CY2019Q4 us-gaap Unbilled Contracts Receivable
UnbilledContractsReceivable
504000000 USD
CY2020Q1 us-gaap Inventory Net
InventoryNet
320000000 USD
CY2019Q4 us-gaap Inventory Net
InventoryNet
332000000 USD
CY2020Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
155000000 USD
CY2019Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
79000000 USD
CY2020Q1 us-gaap Derivative Instruments And Hedges
DerivativeInstrumentsAndHedges
193000000 USD
CY2020Q1 us-gaap Assets Current
AssetsCurrent
2956000000 USD
CY2019Q4 us-gaap Assets Current
AssetsCurrent
2767000000 USD
CY2020Q1 us-gaap Public Utilities Property Plant And Equipment Plant In Service
PublicUtilitiesPropertyPlantAndEquipmentPlantInService
43109000000 USD
CY2019Q4 us-gaap Public Utilities Property Plant And Equipment Plant In Service
PublicUtilitiesPropertyPlantAndEquipmentPlantInService
42709000000 USD
CY2020Q1 us-gaap Public Utilities Property Plant And Equipment Accumulated Depreciation
PublicUtilitiesPropertyPlantAndEquipmentAccumulatedDepreciation
8212000000 USD
CY2019Q4 us-gaap Public Utilities Property Plant And Equipment Accumulated Depreciation
PublicUtilitiesPropertyPlantAndEquipmentAccumulatedDepreciation
8055000000 USD
CY2020Q1 us-gaap Public Utilities Property Plant And Equipment Net
PublicUtilitiesPropertyPlantAndEquipmentNet
34897000000 USD
CY2019Q4 us-gaap Public Utilities Property Plant And Equipment Net
PublicUtilitiesPropertyPlantAndEquipmentNet
34654000000 USD
CY2020Q1 us-gaap Property Plant And Equipment Other
PropertyPlantAndEquipmentOther
380000000 USD
CY2019Q4 us-gaap Property Plant And Equipment Other
PropertyPlantAndEquipmentOther
357000000 USD
CY2020Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
87000000 USD
CY2019Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
109000000 USD
CY2020Q1 ppl Property Plant And Equipment Net Nonregulated
PropertyPlantAndEquipmentNetNonregulated
293000000 USD
CY2019Q4 ppl Property Plant And Equipment Net Nonregulated
PropertyPlantAndEquipmentNetNonregulated
248000000 USD
CY2020Q1 us-gaap Construction In Progress Gross
ConstructionInProgressGross
1645000000 USD
CY2019Q4 us-gaap Construction In Progress Gross
ConstructionInProgressGross
1580000000 USD
CY2020Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
36835000000 USD
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
36482000000 USD
CY2020Q1 us-gaap Regulatory Assets Noncurrent
RegulatoryAssetsNoncurrent
1477000000 USD
CY2019Q4 us-gaap Regulatory Assets Noncurrent
RegulatoryAssetsNoncurrent
1492000000 USD
CY2020Q1 us-gaap Goodwill
Goodwill
3178000000 USD
CY2019Q4 us-gaap Goodwill
Goodwill
3198000000 USD
CY2020Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
748000000 USD
CY2019Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
742000000 USD
CY2020Q1 us-gaap Defined Benefit Plan Assets For Plan Benefits Noncurrent
DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent
603000000 USD
CY2019Q4 us-gaap Defined Benefit Plan Assets For Plan Benefits Noncurrent
DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent
464000000 USD
CY2020Q1 us-gaap Derivative Instruments And Hedges Noncurrent
DerivativeInstrumentsAndHedgesNoncurrent
166000000 USD
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
386000000 USD
CY2019Q4 us-gaap Derivative Instruments And Hedges Noncurrent
DerivativeInstrumentsAndHedgesNoncurrent
149000000 USD
CY2020Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
365000000 USD
CY2019Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
6431000000 USD
CY2020Q1 us-gaap Assets
Assets
46328000000 USD
CY2019Q4 us-gaap Assets
Assets
45680000000 USD
CY2020Q1 us-gaap Short Term Borrowings
ShortTermBorrowings
1696000000 USD
CY2019Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
1151000000 USD
CY2020Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
1170000000 USD
CY2019Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
1172000000 USD
CY2020Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
833000000 USD
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
956000000 USD
CY2020Q1 us-gaap Taxes Payable Current
TaxesPayableCurrent
100000000 USD
CY2019Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
99000000 USD
CY2020Q1 us-gaap Interest Payable Current
InterestPayableCurrent
352000000 USD
CY2019Q4 us-gaap Interest Payable Current
InterestPayableCurrent
294000000 USD
CY2020Q1 us-gaap Dividends Payable Current
DividendsPayableCurrent
319000000 USD
CY2019Q4 us-gaap Dividends Payable Current
DividendsPayableCurrent
317000000 USD
CY2020Q1 ppl Current Customer Deposits
CurrentCustomerDeposits
265000000 USD
CY2019Q4 ppl Current Customer Deposits
CurrentCustomerDeposits
261000000 USD
CY2020Q1 us-gaap Regulatory Liability Current
RegulatoryLiabilityCurrent
99000000 USD
CY2019Q4 us-gaap Regulatory Liability Current
RegulatoryLiabilityCurrent
115000000 USD
CY2020Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
488000000 USD
CY2019Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
535000000 USD
CY2020Q1 us-gaap Liabilities Current
LiabilitiesCurrent
5322000000 USD
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4900000000 USD
CY2020Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
20670000000 USD
CY2019Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
20721000000 USD
CY2020Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
3217000000 USD
CY2019Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
3088000000 USD
CY2020Q1 ppl Deferred Investment Tax Credit
DeferredInvestmentTaxCredit
123000000 USD
CY2019Q4 ppl Deferred Investment Tax Credit
DeferredInvestmentTaxCredit
124000000 USD
CY2020Q1 us-gaap Defined Benefit Pension Plan Liabilities Noncurrent
DefinedBenefitPensionPlanLiabilitiesNoncurrent
500000000 USD
CY2019Q4 us-gaap Defined Benefit Pension Plan Liabilities Noncurrent
DefinedBenefitPensionPlanLiabilitiesNoncurrent
587000000 USD
CY2020Q1 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
217000000 USD
CY2019Q4 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
212000000 USD
CY2020Q1 us-gaap Regulatory Liability Noncurrent
RegulatoryLiabilityNoncurrent
2557000000 USD
CY2019Q4 us-gaap Regulatory Liability Noncurrent
RegulatoryLiabilityNoncurrent
2572000000 USD
CY2020Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
481000000 USD
CY2019Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
485000000 USD
CY2020Q1 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
7095000000 USD
CY2019Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
7068000000 USD
CY2020Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q1 us-gaap Common Stock Value
CommonStockValue
8000000 USD
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
8000000 USD
CY2020Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
12239000000 USD
CY2019Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
12214000000 USD
CY2020Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
5360000000 USD
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
5127000000 USD
CY2020Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-4366000000 USD
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-4358000000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
13241000000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
12991000000 USD
CY2020Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
46328000000 USD
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
45680000000 USD
CY2020Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1560000000 shares
CY2020Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
768266000 shares
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
767233000 shares
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
12991000000 USD
CY2020Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
34000000 USD
CY2020Q1 ppl Stock Based Compensation
StockBasedCompensation
-9000000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
554000000 USD
CY2020Q1 us-gaap Dividends
Dividends
319000000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-8000000 USD
CY2020Q1 us-gaap Cumulative Effect Of New Accounting Principle In Period Of Adoption
CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption
-2000000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
13241000000 USD
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
11657000000 USD
CY2019Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
32000000 USD
CY2019Q1 ppl Stock Based Compensation
StockBasedCompensation
-2000000 USD
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
466000000 USD
CY2019Q1 us-gaap Dividends
Dividends
298000000 USD
CY2019Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
317000000 USD
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
12172000000 USD
CY2020Q1 ppl Votes Per Share Of Common Stock
VotesPerShareOfCommonStock
1 vote
CY2020Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.4150
CY2019Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.4125
CY2020Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
915000000 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
815000000 USD
CY2020Q1 us-gaap Restricted Cash Current
RestrictedCashCurrent
3000000 USD
CY2019Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
3000000 USD
CY2020Q1 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
18000000 USD
CY2019Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
18000000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
936000000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
836000000 USD
CY2020Q1 us-gaap Revenues
Revenues
2054000000 USD
CY2019Q1 us-gaap Revenues
Revenues
2079000000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
554000000 USD
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
466000000 USD
CY2020Q1 us-gaap Assets
Assets
46328000000 USD
CY2019Q4 us-gaap Assets
Assets
45680000000 USD
CY2020Q1 us-gaap Revenues
Revenues
2054000000 USD
CY2020Q1 ppl Alternative Revenue Programs
AlternativeRevenuePrograms
-3000000 USD
CY2020Q1 ppl Other Revenue
OtherRevenue
-10000000 USD
CY2020Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2041000000 USD
CY2019Q1 us-gaap Revenues
Revenues
2079000000 USD
CY2019Q1 ppl Alternative Revenue Programs
AlternativeRevenuePrograms
-6000000 USD
CY2019Q1 ppl Other Revenue
OtherRevenue
-10000000 USD
CY2019Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2063000000 USD
CY2020Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2041000000 USD
CY2019Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2063000000 USD
CY2020Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
8000000 USD
CY2019Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
9000000 USD
CY2019Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
44000000 USD
CY2020Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
42000000 USD
CY2020Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
23000000 USD
CY2018Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
42000000 USD
CY2020Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
553000000 USD
CY2019Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
37000000 USD
CY2019Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
25000000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
554000000 USD
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
466000000 USD
CY2020Q1 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
1000000 USD
CY2019Q1 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
0 USD
CY2019Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
466000000 USD
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
767948000 shares
CY2019Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
721023000 shares
CY2020Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
790000 shares
CY2019Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1023000 shares
CY2020Q1 ppl Incremental Common Shares Attributableto Dilutive Effectof Equity Forward Sales Agreements
IncrementalCommonSharesAttributabletoDilutiveEffectofEquityForwardSalesAgreements
0 shares
CY2019Q1 ppl Incremental Common Shares Attributableto Dilutive Effectof Equity Forward Sales Agreements
IncrementalCommonSharesAttributabletoDilutiveEffectofEquityForwardSalesAgreements
7907000 shares
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
768738000 shares
CY2019Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
729953000 shares
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.72
CY2019Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.65
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.72
CY2019Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.64
CY2020Q1 us-gaap Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
598000 shares
CY2019Q1 us-gaap Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
590000 shares
CY2020Q1 us-gaap Stock Issued During Period Shares Dividend Reinvestment Plan
StockIssuedDuringPeriodSharesDividendReinvestmentPlan
434000 shares
CY2019Q1 us-gaap Stock Issued During Period Shares Dividend Reinvestment Plan
StockIssuedDuringPeriodSharesDividendReinvestmentPlan
458000 shares
CY2020Q1 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
146000000 USD
CY2019Q1 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
124000000 USD
CY2020Q1 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
13000000 USD
CY2019Q1 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
13000000 USD
CY2020Q1 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
6000000 USD
CY2019Q1 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
7000000 USD
CY2020Q1 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
-11000000 USD
CY2019Q1 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
-8000000 USD
CY2020Q1 ppl Amortization Of Excess Deferred Income Taxes
AmortizationOfExcessDeferredIncomeTaxes
-11000000 USD
CY2019Q1 ppl Amortization Of Excess Deferred Income Taxes
AmortizationOfExcessDeferredIncomeTaxes
-11000000 USD
CY2020Q1 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-3000000 USD
CY2019Q1 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
1000000 USD
CY2020Q1 ppl Total Increase Decrease To Federal Income Tax On Income From Continuing Operations At Statutory Tax Rate
TotalIncreaseDecreaseToFederalIncomeTaxOnIncomeFromContinuingOperationsAtStatutoryTaxRate
-6000000 USD
CY2019Q1 ppl Total Increase Decrease To Federal Income Tax On Income From Continuing Operations At Statutory Tax Rate
TotalIncreaseDecreaseToFederalIncomeTaxOnIncomeFromContinuingOperationsAtStatutoryTaxRate
2000000 USD
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
140000000 USD
CY2019Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
126000000 USD
CY2020Q1 us-gaap Regulatory Assets Current
RegulatoryAssetsCurrent
75000000 USD
CY2019Q4 us-gaap Regulatory Assets Current
RegulatoryAssetsCurrent
67000000 USD
CY2020Q1 us-gaap Regulatory Assets Noncurrent
RegulatoryAssetsNoncurrent
1477000000 USD
CY2019Q4 us-gaap Regulatory Assets Noncurrent
RegulatoryAssetsNoncurrent
1492000000 USD
CY2020Q1 us-gaap Regulatory Liability Current
RegulatoryLiabilityCurrent
99000000 USD
CY2019Q4 us-gaap Regulatory Liability Current
RegulatoryLiabilityCurrent
115000000 USD
CY2020Q1 us-gaap Regulatory Liability Noncurrent
RegulatoryLiabilityNoncurrent
2557000000 USD
CY2019Q4 us-gaap Regulatory Liability Noncurrent
RegulatoryLiabilityNoncurrent
2572000000 USD
CY2018Q1 ppl Common Stock Aggregate Sales Price
CommonStockAggregateSalesPrice
1000000000.0 USD
CY2020Q1 ppl Maximum Percentage Paid To Selling Agents
MaximumPercentagePaidToSellingAgents
0.02
CY2020Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
0 shares
CY2020Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.4150
CY2020Q1 ppl Common Stock Dividends Per Share Declared As Per Annum Equivalent
CommonStockDividendsPerShareDeclaredAsPerAnnumEquivalent
1.66
CY2015Q2 ppl Restructuring And Related Activities Ownership Percentage By Riverstone
RestructuringAndRelatedActivitiesOwnershipPercentageByRiverstone
0.35
CY2014Q4 ppl Amount Of Alleged Improper Distribution
AmountOfAllegedImproperDistribution
733000000 USD
CY2020Q1 us-gaap Guarantee Obligations Current Carrying Value
GuaranteeObligationsCurrentCarryingValue
5000000 USD
CY2020Q1 ppl Maximum Aggregate Coverage Bodily Injury And Property Damage
MaximumAggregateCoverageBodilyInjuryAndPropertyDamage
225000000 USD
CY2020Q1 us-gaap Gain Loss From Price Risk Management Activity
GainLossFromPriceRiskManagementActivity
62000000 USD
CY2019Q1 us-gaap Gain Loss From Price Risk Management Activity
GainLossFromPriceRiskManagementActivity
-33000000 USD
CY2020Q1 ppl Defined Benefit Plan Net Periodic Benefit Cost Credit Non Service
DefinedBenefitPlanNetPeriodicBenefitCostCreditNonService
68000000 USD
CY2019Q1 ppl Defined Benefit Plan Net Periodic Benefit Cost Credit Non Service
DefinedBenefitPlanNetPeriodicBenefitCostCreditNonService
80000000 USD
CY2020Q1 us-gaap Interest Income Other
InterestIncomeOther
1000000 USD
CY2019Q1 us-gaap Interest Income Other
InterestIncomeOther
6000000 USD
CY2020Q1 us-gaap Public Utilities Allowance For Funds Used During Construction Capitalized Cost Of Equity
PublicUtilitiesAllowanceForFundsUsedDuringConstructionCapitalizedCostOfEquity
3000000 USD
CY2019Q1 us-gaap Public Utilities Allowance For Funds Used During Construction Capitalized Cost Of Equity
PublicUtilitiesAllowanceForFundsUsedDuringConstructionCapitalizedCostOfEquity
5000000 USD
CY2020Q1 ppl Other Nonoperating Income Miscellaneous
OtherNonoperatingIncomeMiscellaneous
1000000 USD
CY2019Q1 ppl Other Nonoperating Income Miscellaneous
OtherNonoperatingIncomeMiscellaneous
6000000 USD
CY2020Q1 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
135000000 USD
CY2019Q1 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
64000000 USD
CY2020Q1 ppl Charitable Contributions
CharitableContributions
1000000 USD
CY2019Q1 ppl Charitable Contributions
CharitableContributions
2000000 USD
CY2020Q1 ppl Other Nonoperating Expense Miscellaneous
OtherNonoperatingExpenseMiscellaneous
9000000 USD
CY2019Q1 ppl Other Nonoperating Expense Miscellaneous
OtherNonoperatingExpenseMiscellaneous
10000000 USD
CY2020Q1 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
10000000 USD
CY2019Q1 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
12000000 USD
CY2020Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
125000000 USD
CY2019Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
52000000 USD
CY2020Q1 us-gaap Derivative Collateral Obligation To Return Cash
DerivativeCollateralObligationToReturnCash
29000000 USD
CY2019Q4 us-gaap Derivative Collateral Obligation To Return Cash
DerivativeCollateralObligationToReturnCash
14000000 USD
CY2020Q1 us-gaap Gain Loss On Discontinuation Of Interest Rate Cash Flow Hedge Due To Forecasted Transaction Probable Of Not Occurring Net
GainLossOnDiscontinuationOfInterestRateCashFlowHedgeDueToForecastedTransactionProbableOfNotOccurringNet
0 USD
CY2020Q1 us-gaap Interest Expense
InterestExpense
248000000 USD
CY2020Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
125000000 USD
CY2020Q1 ppl Derivative Net Liability Position Aggregate Fair Value Alternative
DerivativeNetLiabilityPositionAggregateFairValueAlternative
6000000 USD
CY2020Q1 us-gaap Collateral Already Posted Aggregate Fair Value
CollateralAlreadyPostedAggregateFairValue
0 USD
CY2020Q1 us-gaap Additional Collateral Aggregate Fair Value
AdditionalCollateralAggregateFairValue
6000000 USD
CY2019Q4 us-gaap Asset Retirement Obligation
AssetRetirementObligation
282000000 USD
CY2020Q1 us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
4000000 USD
CY2020Q1 us-gaap Asset Retirement Obligation Revision Of Estimate
AssetRetirementObligationRevisionOfEstimate
18000000 USD
CY2020Q1 us-gaap Asset Retirement Obligation Liabilities Settled
AssetRetirementObligationLiabilitiesSettled
20000000 USD
CY2020Q1 us-gaap Asset Retirement Obligation
AssetRetirementObligation
284000000 USD
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-4358000000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
-53000000 USD
CY2020Q1 us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
45000000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-8000000 USD
CY2020Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-4366000000 USD
CY2018Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-3964000000 USD
CY2019Q1 us-gaap Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
272000000 USD
CY2019Q1 us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
45000000 USD
CY2019Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
317000000 USD
CY2019Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-3647000000 USD

Files In Submission

Name View Source Status
0000922224-20-000024-index-headers.html Edgar Link pending
0000922224-20-000024-index.html Edgar Link pending
0000922224-20-000024.txt Edgar Link pending
0000922224-20-000024-xbrl.zip Edgar Link pending
exhibit10ahtmlfriendly.htm Edgar Link pending
exhibit10ahtmlfriendly001.jpg Edgar Link pending
exhibit10ahtmlfriendly002.jpg Edgar Link pending
exhibit10ahtmlfriendly003.jpg Edgar Link pending
exhibit10ahtmlfriendly004.jpg Edgar Link pending
exhibit10ahtmlfriendly005.jpg Edgar Link pending
exhibit10ahtmlfriendly006.jpg Edgar Link pending
exhibit10ahtmlfriendly007.jpg Edgar Link pending
exhibit10ahtmlfriendly008.jpg Edgar Link pending
exhibit10ahtmlfriendly009.jpg Edgar Link pending
exhibit10ahtmlfriendly010.jpg Edgar Link pending
exhibit10ahtmlfriendly011.jpg Edgar Link pending
exhibit10ahtmlfriendly012.jpg Edgar Link pending
exhibit10ahtmlfriendly013.jpg Edgar Link pending
exhibit10ahtmlfriendly014.jpg Edgar Link pending
exhibit10ahtmlfriendly015.jpg Edgar Link pending
exhibit10ahtmlfriendly016.jpg Edgar Link pending
exhibit10ahtmlfriendly017.jpg Edgar Link pending
exhibit10ahtmlfriendly018.jpg Edgar Link pending
exhibit10ahtmlfriendly019.jpg Edgar Link pending
exhibit10ahtmlfriendly020.jpg Edgar Link pending
exhibit10ahtmlfriendly021.jpg Edgar Link pending
exhibit10ahtmlfriendly022.jpg Edgar Link pending
exhibit10ahtmlfriendly023.jpg Edgar Link pending
exhibit10ahtmlfriendly024.jpg Edgar Link pending
exhibit10ahtmlfriendly025.jpg Edgar Link pending
exhibit10ahtmlfriendly026.jpg Edgar Link pending
exhibit10ahtmlfriendly027.jpg Edgar Link pending
exhibit10ahtmlfriendly028.jpg Edgar Link pending
exhibit10ahtmlfriendly029.jpg Edgar Link pending
exhibit10ahtmlfriendly030.jpg Edgar Link pending
exhibit10ahtmlfriendly031.jpg Edgar Link pending
exhibit10ahtmlfriendly032.jpg Edgar Link pending
exhibit10ahtmlfriendly033.jpg Edgar Link pending
exhibit10ahtmlfriendly034.jpg Edgar Link pending
exhibit10ahtmlfriendly035.jpg Edgar Link pending
exhibit10ahtmlfriendly036.jpg Edgar Link pending
exhibit10ahtmlfriendly037.jpg Edgar Link pending
exhibit10ahtmlfriendly038.jpg Edgar Link pending
exhibit10ahtmlfriendly039.jpg Edgar Link pending
exhibit10ahtmlfriendly040.jpg Edgar Link pending
exhibit10ahtmlfriendly041.jpg Edgar Link pending
exhibit10ahtmlfriendly042.jpg Edgar Link pending
exhibit10ahtmlfriendly043.jpg Edgar Link pending
exhibit10ahtmlfriendly044.jpg Edgar Link pending
exhibit10ahtmlfriendly045.jpg Edgar Link pending
exhibit10ahtmlfriendly046.jpg Edgar Link pending
exhibit10ahtmlfriendly047.jpg Edgar Link pending
exhibit10ahtmlfriendly048.jpg Edgar Link pending
exhibit10ahtmlfriendly049.jpg Edgar Link pending
exhibit10ahtmlfriendly050.jpg Edgar Link pending
exhibit10ahtmlfriendly051.jpg Edgar Link pending
exhibit10ahtmlfriendly052.jpg Edgar Link pending
exhibit10ahtmlfriendly053.jpg Edgar Link pending
exhibit10ahtmlfriendly054.jpg Edgar Link pending
exhibit10ahtmlfriendly055.jpg Edgar Link pending
exhibit10ahtmlfriendly056.jpg Edgar Link pending
exhibit10ahtmlfriendly057.jpg Edgar Link pending
exhibit10ahtmlfriendly058.jpg Edgar Link pending
exhibit10ahtmlfriendly059.jpg Edgar Link pending
exhibit10ahtmlfriendly060.jpg Edgar Link pending
exhibit10ahtmlfriendly061.jpg Edgar Link pending
exhibit10ahtmlfriendly062.jpg Edgar Link pending
exhibit10ahtmlfriendly063.jpg Edgar Link pending
exhibit10ahtmlfriendly064.jpg Edgar Link pending
exhibit10ahtmlfriendly065.jpg Edgar Link pending
exhibit10ahtmlfriendly066.jpg Edgar Link pending
exhibit10ahtmlfriendly067.jpg Edgar Link pending
exhibit10ahtmlfriendly068.jpg Edgar Link pending
exhibit10ahtmlfriendly069.jpg Edgar Link pending
exhibit10ahtmlfriendly070.jpg Edgar Link pending
exhibit10ahtmlfriendly071.jpg Edgar Link pending
exhibit10ahtmlfriendly072.jpg Edgar Link pending
exhibit10ahtmlfriendly073.jpg Edgar Link pending
exhibit10ahtmlfriendly074.jpg Edgar Link pending
exhibit10ahtmlfriendly075.jpg Edgar Link pending
exhibit10ahtmlfriendly076.jpg Edgar Link pending
exhibit10ahtmlfriendly077.jpg Edgar Link pending
exhibit10ahtmlfriendly078.jpg Edgar Link pending
exhibit10ahtmlfriendly079.jpg Edgar Link pending
exhibit10ahtmlfriendly080.jpg Edgar Link pending
exhibit10ahtmlfriendly081.jpg Edgar Link pending
exhibit10bhtmlfriendly.htm Edgar Link pending
exhibit10bhtmlfriendly001.jpg Edgar Link pending
exhibit10bhtmlfriendly002.jpg Edgar Link pending
exhibit10bhtmlfriendly003.jpg Edgar Link pending
exhibit10bhtmlfriendly004.jpg Edgar Link pending
exhibit10bhtmlfriendly005.jpg Edgar Link pending
exhibit10bhtmlfriendly006.jpg Edgar Link pending
exhibit10bhtmlfriendly007.jpg Edgar Link pending
exhibit10bhtmlfriendly008.jpg Edgar Link pending
exhibit10bhtmlfriendly009.jpg Edgar Link pending
exhibit10bhtmlfriendly010.jpg Edgar Link pending
exhibit10bhtmlfriendly011.jpg Edgar Link pending
exhibit10bhtmlfriendly012.jpg Edgar Link pending
exhibit10bhtmlfriendly013.jpg Edgar Link pending
exhibit10bhtmlfriendly014.jpg Edgar Link pending
exhibit10bhtmlfriendly015.jpg Edgar Link pending
exhibit10bhtmlfriendly016.jpg Edgar Link pending
exhibit10bhtmlfriendly017.jpg Edgar Link pending
exhibit10bhtmlfriendly018.jpg Edgar Link pending
exhibit10bhtmlfriendly019.jpg Edgar Link pending
exhibit10bhtmlfriendly020.jpg Edgar Link pending
exhibit10bhtmlfriendly021.jpg Edgar Link pending
exhibit10bhtmlfriendly022.jpg Edgar Link pending
exhibit10bhtmlfriendly023.jpg Edgar Link pending
exhibit10bhtmlfriendly024.jpg Edgar Link pending
exhibit10bhtmlfriendly025.jpg Edgar Link pending
exhibit10bhtmlfriendly026.jpg Edgar Link pending
exhibit10bhtmlfriendly027.jpg Edgar Link pending
exhibit10bhtmlfriendly028.jpg Edgar Link pending
exhibit10bhtmlfriendly029.jpg Edgar Link pending
exhibit10bhtmlfriendly030.jpg Edgar Link pending
exhibit10bhtmlfriendly031.jpg Edgar Link pending
exhibit10bhtmlfriendly032.jpg Edgar Link pending
exhibit10bhtmlfriendly033.jpg Edgar Link pending
exhibit10bhtmlfriendly034.jpg Edgar Link pending
exhibit10bhtmlfriendly035.jpg Edgar Link pending
exhibit10bhtmlfriendly036.jpg Edgar Link pending
exhibit10bhtmlfriendly037.jpg Edgar Link pending
exhibit10bhtmlfriendly038.jpg Edgar Link pending
exhibit10bhtmlfriendly039.jpg Edgar Link pending
exhibit10bhtmlfriendly040.jpg Edgar Link pending
exhibit10bhtmlfriendly041.jpg Edgar Link pending
exhibit10bhtmlfriendly042.jpg Edgar Link pending
exhibit10bhtmlfriendly043.jpg Edgar Link pending
exhibit10bhtmlfriendly044.jpg Edgar Link pending
exhibit10bhtmlfriendly045.jpg Edgar Link pending
exhibit10bhtmlfriendly046.jpg Edgar Link pending
exhibit10bhtmlfriendly047.jpg Edgar Link pending
exhibit10bhtmlfriendly048.jpg Edgar Link pending
exhibit10bhtmlfriendly049.jpg Edgar Link pending
exhibit10bhtmlfriendly050.jpg Edgar Link pending
exhibit10bhtmlfriendly051.jpg Edgar Link pending
exhibit10bhtmlfriendly052.jpg Edgar Link pending
exhibit10bhtmlfriendly053.jpg Edgar Link pending
exhibit10bhtmlfriendly054.jpg Edgar Link pending
exhibit10bhtmlfriendly055.jpg Edgar Link pending
exhibit10bhtmlfriendly056.jpg Edgar Link pending
exhibit10bhtmlfriendly057.jpg Edgar Link pending
exhibit10bhtmlfriendly058.jpg Edgar Link pending
exhibit10bhtmlfriendly059.jpg Edgar Link pending
exhibit10bhtmlfriendly060.jpg Edgar Link pending
exhibit10bhtmlfriendly061.jpg Edgar Link pending
exhibit10bhtmlfriendly062.jpg Edgar Link pending
exhibit10bhtmlfriendly063.jpg Edgar Link pending
exhibit10bhtmlfriendly064.jpg Edgar Link pending
exhibit10bhtmlfriendly065.jpg Edgar Link pending
exhibit10bhtmlfriendly066.jpg Edgar Link pending
exhibit10bhtmlfriendly067.jpg Edgar Link pending
exhibit10bhtmlfriendly068.jpg Edgar Link pending
exhibit10bhtmlfriendly069.jpg Edgar Link pending
exhibit10bhtmlfriendly070.jpg Edgar Link pending
exhibit10bhtmlfriendly071.jpg Edgar Link pending
exhibit10bhtmlfriendly072.jpg Edgar Link pending
exhibit10bhtmlfriendly073.jpg Edgar Link pending
exhibit10bhtmlfriendly074.jpg Edgar Link pending
exhibit10bhtmlfriendly075.jpg Edgar Link pending
exhibit10bhtmlfriendly076.jpg Edgar Link pending
exhibit10bhtmlfriendly077.jpg Edgar Link pending
exhibit10bhtmlfriendly078.jpg Edgar Link pending
exhibit10bhtmlfriendly079.jpg Edgar Link pending
exhibit10bhtmlfriendly080.jpg Edgar Link pending
exhibit10bhtmlfriendly081.jpg Edgar Link pending
exhibit10chtmlfriendly.htm Edgar Link pending
exhibit10chtmlfriendly001.jpg Edgar Link pending
exhibit10chtmlfriendly002.jpg Edgar Link pending
exhibit10chtmlfriendly003.jpg Edgar Link pending
exhibit10chtmlfriendly004.jpg Edgar Link pending
exhibit10chtmlfriendly005.jpg Edgar Link pending
exhibit10chtmlfriendly006.jpg Edgar Link pending
exhibit10chtmlfriendly007.jpg Edgar Link pending
exhibit10chtmlfriendly008.jpg Edgar Link pending
exhibit10chtmlfriendly009.jpg Edgar Link pending
exhibit10chtmlfriendly010.jpg Edgar Link pending
exhibit10chtmlfriendly011.jpg Edgar Link pending
exhibit10chtmlfriendly012.jpg Edgar Link pending
exhibit10chtmlfriendly013.jpg Edgar Link pending
exhibit10chtmlfriendly014.jpg Edgar Link pending
exhibit10chtmlfriendly015.jpg Edgar Link pending
exhibit10chtmlfriendly016.jpg Edgar Link pending
exhibit10chtmlfriendly017.jpg Edgar Link pending
exhibit10chtmlfriendly018.jpg Edgar Link pending
exhibit10chtmlfriendly019.jpg Edgar Link pending
exhibit10chtmlfriendly020.jpg Edgar Link pending
exhibit10chtmlfriendly021.jpg Edgar Link pending
exhibit10chtmlfriendly022.jpg Edgar Link pending
exhibit10chtmlfriendly023.jpg Edgar Link pending
exhibit10chtmlfriendly024.jpg Edgar Link pending
exhibit10chtmlfriendly025.jpg Edgar Link pending
exhibit10chtmlfriendly026.jpg Edgar Link pending
exhibit10chtmlfriendly027.jpg Edgar Link pending
exhibit10chtmlfriendly028.jpg Edgar Link pending
exhibit10chtmlfriendly029.jpg Edgar Link pending
exhibit10chtmlfriendly030.jpg Edgar Link pending
exhibit10chtmlfriendly031.jpg Edgar Link pending
exhibit10chtmlfriendly032.jpg Edgar Link pending
exhibit10chtmlfriendly033.jpg Edgar Link pending
exhibit10chtmlfriendly034.jpg Edgar Link pending
exhibit10chtmlfriendly035.jpg Edgar Link pending
exhibit10chtmlfriendly036.jpg Edgar Link pending
exhibit10chtmlfriendly037.jpg Edgar Link pending
exhibit10chtmlfriendly038.jpg Edgar Link pending
exhibit10chtmlfriendly039.jpg Edgar Link pending
exhibit10chtmlfriendly040.jpg Edgar Link pending
exhibit10chtmlfriendly041.jpg Edgar Link pending
exhibit10chtmlfriendly042.jpg Edgar Link pending
exhibit10chtmlfriendly043.jpg Edgar Link pending
exhibit10chtmlfriendly044.jpg Edgar Link pending
exhibit10chtmlfriendly045.jpg Edgar Link pending
exhibit10chtmlfriendly046.jpg Edgar Link pending
exhibit10chtmlfriendly047.jpg Edgar Link pending
exhibit10chtmlfriendly048.jpg Edgar Link pending
exhibit10chtmlfriendly049.jpg Edgar Link pending
exhibit10chtmlfriendly050.jpg Edgar Link pending
exhibit10chtmlfriendly051.jpg Edgar Link pending
exhibit10chtmlfriendly052.jpg Edgar Link pending
exhibit10chtmlfriendly053.jpg Edgar Link pending
exhibit10chtmlfriendly054.jpg Edgar Link pending
exhibit10chtmlfriendly055.jpg Edgar Link pending
exhibit10chtmlfriendly056.jpg Edgar Link pending
exhibit10chtmlfriendly057.jpg Edgar Link pending
exhibit10chtmlfriendly058.jpg Edgar Link pending
exhibit10chtmlfriendly059.jpg Edgar Link pending
exhibit10chtmlfriendly060.jpg Edgar Link pending
exhibit10chtmlfriendly061.jpg Edgar Link pending
exhibit10chtmlfriendly062.jpg Edgar Link pending
exhibit10chtmlfriendly063.jpg Edgar Link pending
exhibit10chtmlfriendly064.jpg Edgar Link pending
exhibit10chtmlfriendly065.jpg Edgar Link pending
exhibit10chtmlfriendly066.jpg Edgar Link pending
exhibit10chtmlfriendly067.jpg Edgar Link pending
exhibit10chtmlfriendly068.jpg Edgar Link pending
exhibit10chtmlfriendly069.jpg Edgar Link pending
exhibit10chtmlfriendly070.jpg Edgar Link pending
exhibit10chtmlfriendly071.jpg Edgar Link pending
exhibit10chtmlfriendly072.jpg Edgar Link pending
exhibit10chtmlfriendly073.jpg Edgar Link pending
exhibit10chtmlfriendly074.jpg Edgar Link pending
exhibit10chtmlfriendly075.jpg Edgar Link pending
exhibit10chtmlfriendly076.jpg Edgar Link pending
exhibit10chtmlfriendly077.jpg Edgar Link pending
exhibit10dhtmlfriendly.htm Edgar Link pending
exhibit10dhtmlfriendly001.jpg Edgar Link pending
exhibit10dhtmlfriendly002.jpg Edgar Link pending
exhibit10dhtmlfriendly003.jpg Edgar Link pending
exhibit10dhtmlfriendly004.jpg Edgar Link pending
exhibit10dhtmlfriendly005.jpg Edgar Link pending
exhibit10dhtmlfriendly006.jpg Edgar Link pending
exhibit10dhtmlfriendly007.jpg Edgar Link pending
exhibit10dhtmlfriendly008.jpg Edgar Link pending
exhibit10dhtmlfriendly009.jpg Edgar Link pending
exhibit10dhtmlfriendly010.jpg Edgar Link pending
exhibit10dhtmlfriendly011.jpg Edgar Link pending
exhibit10dhtmlfriendly012.jpg Edgar Link pending
exhibit10dhtmlfriendly013.jpg Edgar Link pending
exhibit10dhtmlfriendly014.jpg Edgar Link pending
exhibit10dhtmlfriendly015.jpg Edgar Link pending
exhibit10dhtmlfriendly016.jpg Edgar Link pending
exhibit10dhtmlfriendly017.jpg Edgar Link pending
exhibit10dhtmlfriendly018.jpg Edgar Link pending
exhibit10dhtmlfriendly019.jpg Edgar Link pending
exhibit10dhtmlfriendly020.jpg Edgar Link pending
exhibit10dhtmlfriendly021.jpg Edgar Link pending
exhibit10dhtmlfriendly022.jpg Edgar Link pending
exhibit10dhtmlfriendly023.jpg Edgar Link pending
exhibit10dhtmlfriendly024.jpg Edgar Link pending
exhibit10dhtmlfriendly025.jpg Edgar Link pending
exhibit10dhtmlfriendly026.jpg Edgar Link pending
exhibit10dhtmlfriendly027.jpg Edgar Link pending
exhibit10dhtmlfriendly028.jpg Edgar Link pending
exhibit10dhtmlfriendly029.jpg Edgar Link pending
exhibit10dhtmlfriendly030.jpg Edgar Link pending
exhibit10dhtmlfriendly031.jpg Edgar Link pending
exhibit10dhtmlfriendly032.jpg Edgar Link pending
exhibit10dhtmlfriendly033.jpg Edgar Link pending
exhibit10dhtmlfriendly034.jpg Edgar Link pending
exhibit10dhtmlfriendly035.jpg Edgar Link pending
exhibit10dhtmlfriendly036.jpg Edgar Link pending
exhibit10dhtmlfriendly037.jpg Edgar Link pending
exhibit10dhtmlfriendly038.jpg Edgar Link pending
exhibit10dhtmlfriendly039.jpg Edgar Link pending
exhibit10dhtmlfriendly040.jpg Edgar Link pending
exhibit10dhtmlfriendly041.jpg Edgar Link pending
exhibit10dhtmlfriendly042.jpg Edgar Link pending
exhibit10dhtmlfriendly043.jpg Edgar Link pending
exhibit10dhtmlfriendly044.jpg Edgar Link pending
exhibit10dhtmlfriendly045.jpg Edgar Link pending
exhibit10dhtmlfriendly046.jpg Edgar Link pending
exhibit10dhtmlfriendly047.jpg Edgar Link pending
exhibit10dhtmlfriendly048.jpg Edgar Link pending
exhibit10dhtmlfriendly049.jpg Edgar Link pending
exhibit10dhtmlfriendly050.jpg Edgar Link pending
exhibit10dhtmlfriendly051.jpg Edgar Link pending
exhibit10dhtmlfriendly052.jpg Edgar Link pending
exhibit10dhtmlfriendly053.jpg Edgar Link pending
exhibit10dhtmlfriendly054.jpg Edgar Link pending
exhibit10dhtmlfriendly055.jpg Edgar Link pending
exhibit10dhtmlfriendly056.jpg Edgar Link pending
exhibit10dhtmlfriendly057.jpg Edgar Link pending
exhibit10dhtmlfriendly058.jpg Edgar Link pending
exhibit10dhtmlfriendly059.jpg Edgar Link pending
exhibit10dhtmlfriendly060.jpg Edgar Link pending
exhibit10dhtmlfriendly061.jpg Edgar Link pending
exhibit10dhtmlfriendly062.jpg Edgar Link pending
exhibit10dhtmlfriendly063.jpg Edgar Link pending
exhibit10dhtmlfriendly064.jpg Edgar Link pending
exhibit10dhtmlfriendly065.jpg Edgar Link pending
exhibit10dhtmlfriendly066.jpg Edgar Link pending
exhibit10dhtmlfriendly067.jpg Edgar Link pending
exhibit10dhtmlfriendly068.jpg Edgar Link pending
exhibit10dhtmlfriendly069.jpg Edgar Link pending
exhibit10dhtmlfriendly070.jpg Edgar Link pending
exhibit10dhtmlfriendly071.jpg Edgar Link pending
exhibit10dhtmlfriendly072.jpg Edgar Link pending
exhibit10dhtmlfriendly073.jpg Edgar Link pending
exhibit10dhtmlfriendly074.jpg Edgar Link pending
exhibit10dhtmlfriendly075.jpg Edgar Link pending
exhibit10ehtmlfriendly.htm Edgar Link pending
exhibit10ehtmlfriendly001.jpg Edgar Link pending
exhibit10ehtmlfriendly002.jpg Edgar Link pending
exhibit10ehtmlfriendly003.jpg Edgar Link pending
exhibit10ehtmlfriendly004.jpg Edgar Link pending
exhibit10ehtmlfriendly005.jpg Edgar Link pending
exhibit10ehtmlfriendly006.jpg Edgar Link pending
exhibit10ehtmlfriendly007.jpg Edgar Link pending
exhibit10ehtmlfriendly008.jpg Edgar Link pending
exhibit10ehtmlfriendly009.jpg Edgar Link pending
exhibit10ehtmlfriendly010.jpg Edgar Link pending
exhibit10ehtmlfriendly011.jpg Edgar Link pending
exhibit10ehtmlfriendly012.jpg Edgar Link pending
exhibit10ehtmlfriendly013.jpg Edgar Link pending
exhibit10ehtmlfriendly014.jpg Edgar Link pending
exhibit10ehtmlfriendly015.jpg Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
ppl-20200331.xsd Edgar Link pending
ppl-20200331_cal.xml Edgar Link unprocessable
ppl-20200331_def.xml Edgar Link unprocessable
ppl-20200331_lab.xml Edgar Link unprocessable
ppl-20200331_pre.xml Edgar Link unprocessable
ppl-3312020ex31a.htm Edgar Link pending
ppl-3312020ex31b.htm Edgar Link pending
ppl-3312020ex31c.htm Edgar Link pending
ppl-3312020ex31d.htm Edgar Link pending
ppl-3312020ex31e.htm Edgar Link pending
ppl-3312020ex31f.htm Edgar Link pending
ppl-3312020ex31g.htm Edgar Link pending
ppl-3312020ex31h.htm Edgar Link pending
ppl-3312020ex31i.htm Edgar Link pending
ppl-3312020ex31j.htm Edgar Link pending
ppl-3312020ex32a.htm Edgar Link pending
ppl-3312020ex32b.htm Edgar Link pending
ppl-3312020ex32c.htm Edgar Link pending
ppl-3312020ex32d.htm Edgar Link pending
ppl-3312020ex32e.htm Edgar Link pending
ppl-3312020x10q.htm Edgar Link pending
ppl-3312020x10q_htm.xml Edgar Link completed
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending